Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability

Epilepsy and Behavior

Volumn 13, Issue 2, 2008, Pages 397-401

  Huber, Bernd ^a   Bocchicchio, Michelina ^a   Feuerbaum, Elisabeth ^a   May, Theodor ^b   Meinert, Thomas ^a   Robertson, Enrique ^a   Schorlemmer, Heide ^a   Wagner, Wolfgang ^a   Wilking, Elisabeth ^a   Seidel, Michael ^a  

^a EPILEPSY CENTER BETHEL   (Germany)

^b Society for Epilepsy Research   (Germany)

Author keywords

Antiepileptic drug; Epilepsy; Intellectual disability; Pregabalin; Therapy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PREGABALIN; VALPROIC ACID;

ACCIDENTAL INJURY; ADD ON THERAPY; AGGRESSION; AMBLYOPIA; ARTICLE; ASTHENIA; ATAXIA; AUTOMUTILATION; BLURRED VISION; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIPLOPIA; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOCAL EPILEPSY; FUNCTIONAL STATUS; HOSPITAL PATIENT; HUMAN; INTELLECTUAL IMPAIRMENT; LENNOX GASTAUT SYNDROME; LOW DRUG DOSE; MALE; MENTAL DEFICIENCY; OUTCOME ASSESSMENT; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; THOUGHT DISORDER; TONIC CLONIC SEIZURE; TONIC SEIZURE; TREMOR; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MENTAL RETARDATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 45649085242     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.04.021     Document Type: Article

References (12)

1. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., and Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60 (2003) 1631-1637
2. Arroyo S., Anhut H., Kugler A.R., et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 (2004) 20-27
3. Beydoun A., Uthman B.M., Kugler A.R., Greiner M.J., Knapp L.E., and Garofalo E.A. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64 (2005) 475-480
4. Linden M., Baier D., Beitinger H., et al. Leitlinien zur Durchführung von Anwendungsbeobachtungen in der Psychopharmakatherapie. Der Nervenarzt 65 (1994) 638-644
5. Association for Methodology and Documentation in Psychiatry (AMDP), Collegium Internationale Psychiatriae Scalarum (CIPS). Rating scales for psychiatry. European ed. Weinheim: Beltz Test GmbH; 1990.
6. Engel Jr. J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42 (2001) 796-803
7. Carreňo M., Maestro I., Molins A., et al. Pregabalin as add-on therapy for refractory partial seizures in everyday clinical practice. Seizure 16 (2007) 709-712
8. Simister R.J., Sander J.W., and Koepp M.J. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability. Epilepsy Behav 10 (2007) 336-339
9. Huber B., May T., and Seidel M. Lamotrigine in multihandicapped therapy-resistant epileptic patients. Clin Drug Invest 16 (1998) 263-277
10. Huber B. [Effects of topiramate in patients with epilepsy and intellectual deficits]. Nervenarzt 73 (2002) 525-532
11. Huber B., and Tomka-Hoffmeister M. Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients. Seizure 12 (2003) 602-603
12. Huber B., Bömmel W., Hauser I., et al. Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities. Seizure 13 (2004) 168-175